Filing Flows › Stemtech (STEK) › Q2 2025
Stemtech (STEK) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 19, 2025
Stemtech (STEK) reported revenue of $698K for the second quarter 2025 (Q2 2025), -47% from a year earlier and -20% from the quarter before. Operating margin was -43.1%, net loss $296K (42.5% of revenue).
Stemtech, Q2 2025: revenue $698K (-47% year over year), operating margin -43.1%, net loss $296K, operating cash flow $75K. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $698K | -20% | -47% |
| Operating profit | −$301K | — | — |
| Net earnings | −$296K | — | — |
| Operating cash flow | $75K | — | — |
What changed
Revenue was $698K in Q2 2025, down 47% year over year and down 20% from the previous quarter.
Gross margin was 79.1%, up 4.1 points from a year earlier. Operating costs exceeded revenue by $301K, an operating margin of -43.1%. Operating expenses fell 49% while revenue fell 47%. The quarter ended with a net loss of $296K, narrower than the previous quarter's $1.5M loss. Minority interests bore $3K of it: to shareholders the quarter was a loss of $293K.
Operating cash flow was $75K. Non-cash charges added back $42K of depreciation and amortization and $109K of share-based compensation. Working capital and other items added $220K.
Questions
What was Stemtech's revenue in the second quarter 2025?
Stemtech (STEK) reported revenue of $698K for the second quarter 2025 (Q2 2025), -47% from a year earlier and -20% from the quarter before.
Was Stemtech profitable in the second quarter 2025?
Operating loss was $301K (-43.1% of revenue) and net loss $296K.
Source: Stemtech 10-Q on SEC EDGAR.